Microhealth
What we do? We develop digital therapeutics to address unmet medical needs in hematology and oncology. How it works? First we build networks of doctors and patients designed to track, predict and prevent disease. Second, we validate the safety and efficacy of our interventions in pivotal clinical studies to obtain regulatory clearance (SaMD). Finally, we aim to commercialize our products as prescription digital therapeutics (DTx). Where are we now? Today, we are the standard in digital hematolog
Y Combinator
yc-company-directory #1002What we do? We develop digital therapeutics to address unmet medical needs in hematology and oncology. How it works? First we build networks of doctors and patients designed to track, predict and prevent disease. Second, we validate the safety and efficacy of our interventions in pivotal clinical studies to obtain regulatory clearance (SaMD). Finally, we aim to commercialize our products as prescription digital therapeutics (DTx). Where are we now? Today, we are the standard in digital hematolog
sourceMicrohealth is classified as AI infrastructure from source descriptions and fund-directory context. Similar companies below are ranked from offline product facets and meaningful description overlap; category and source affiliation can only strengthen an existing product match. For lookup-created rows, the profile starts as pending enrichment until deeper source collection runs.
Local clusters rerank extracted product concepts and description terms. The generated graph remains the fallback for sparse descriptions: offline reciprocal product-similarity graph: extracted concepts + description terms + bounded category/affiliation boosts. Minimum fallback score: 0; max competitors: 6.
Companies similar to Microhealth
A deterministic local cluster built from offline product facets and meaningful description terms. Category and selected-institution affiliation provide bounded tie-breaks. Open any peer to continue exploring its cluster.
Coral Genomics
match 100Coral integrates molecular, functional, and clinical factors to create new clinical laboratory tests that predict optimal treatments for autoimmune diseases. We have also identified a unique subpopulation of patients who do not respond to current therapies and are working towards addressing this unmet medical need.
shared extracted concept terms: unmet, medical, need; shared product terms: clinical, predict, disease, patient; shared product theme: health and clinical care; shared affiliation: Y Combinator
Keylika
match 74Keylika is an early stage biopharma startup developing metal-based drugs using a platform synthesis technology to treat unmet medical needs. We then administer these drugs using proven delivery technologies to effect the best clinical outcomes. Our first product is a small molecule iron drug (new molecular entity) delivered by a wearable skin patch to treat Iron Deficiency Anemia (IDA), with significantly higher safety, efficacy and tolerability over existing treatments. This is poised to be a b
shared extracted concepts: unmet medical needs; shared product terms: develop, unmet, medical, need; shared product theme: health and clinical care; shared affiliation: Y Combinator
Mednet
match 59Mednet helps doctors answer their toughest clinical questions — blending AI, medical literature, and real-world physician expertise. Co-founded by siblings Samir Housri and Dr. Nadine Housri while navigating their father's cancer treatment, Mednet was created to capture the undocumented clinical knowledge that makes the difference in patient care. Today, over 40,000 US physicians use Mednet to navigate complex cases, make better-informed decisions, and shape industry innovation — ensuring that e
shared extracted concept terms: medical; shared product terms: doctor, clinical, medical, patient; shared product theme: health and clinical care; same category: AI infrastructure; shared affiliation: Y Combinator
ParcelBio
match 56ParcelBio is engineering a new class of mRNA medicines designed to deliver unprecedented potency and durability. Its proprietary APEXm™ platform uses novel RNA domains to enhance protein expression and extend activity, enabling therapies that reach the thresholds required for meaningful, and potentially curative, clinical outcomes. The company is advancing programs in autoimmune disease, oncology, and encoded protein therapeutics.
shared extracted concept terms: oncology; shared product terms: therapeutic, oncology, design, disease; shared product theme: health and clinical care; shared affiliation: Y Combinator
Melon Health
match 47Digital therapeutics for physical, emotional and social health. Melon combines behavior science, data and design to deliver evidence based wellness interventions supported by humans and enabled by technology.
shared extracted concept terms: digital; shared product terms: digital, therapeutic, design, intervention; shared product theme: health and clinical care
Canopie
match 47Canopie is a digital platform that provides new moms with personalized, evidence-based therapeutic techniques to prevent and address symptoms of maternal depression and anxiety.
shared extracted concept terms: digital; shared product terms: digital, therapeutic, prevent, addres; shared product theme: health and clinical care